[HTML][HTML] Comprehensive Review of Cyclamen: Development, Bioactive Properties, and Therapeutic Applications

A Sharara, A Badran, A Hijazi, G Albahri, M Bechelany… - Pharmaceuticals, 2024 - mdpi.com
Plants are being researched as potential sources of novel drugs, which has led to a recent
acceleration in the discovery of new bioactive compounds. Research on tissue culture …

Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to …

MN Murugappan, BL King-Kallimanis… - Journal of Geriatric …, 2024 - Elsevier
Introduction Frailty assessments may help to identify patients at highest risk for treatment-
related toxicity, early treatment discontinuation due to toxicity, and death in Multiple …

Measuring Frailty In Relapsed/Refractory Multiple Myeloma Using Patient-Reported Outcomes Data

M Murugappan - 2024 - conservancy.umn.edu
Current frailty measurement systems in Multiple Myeloma weight patients' chronological age
heavily. The aim of this research was to explore the feasibility of measuring frailty in patients …